Miloš, a seven-year-old boy battling a particularly challenging rare genetic condition, dystrophic bullous epidermolysis, has faced this relentless illness since his birth. Often referred to as “butterfly children” due to the astonishing fragility of their skin, resembling delicate butterfly wings, he experiences constant distress. His body is perpetually covered in open, bleeding wounds, easily triggered by even the lightest touch.
Movement and routine bandaging are sources of significant discomfort for him. For over a year, Miloš endured a lengthy wait for appropriate treatment. Historically, there were no effective medications or therapies available for this devastating disease.
However, a significant advancement occurred in 2023 when the United States authorized the initial gene therapy for this condition. This innovative therapy, named Vyjuvek, marks a revolutionary step in managing bullous epidermolysis. It directly addresses the underlying cause of the disease, offering a truly transformative approach.
Topics: #butterfly #boy #disease
